Alzheimer’s Drug Slows Decline In Memory And Thinking In Phase 2 Trial
The pharmaceutical companies Eisai and Biogen have presented results of a phase 2 clinical trial of the potential Alzheimer’s disease drug, BAN2401. The presentation at the…
Read more...